Pathogenetic role of autoantibodies in neurological diseases

Trends in Neurosciences

Volumn 23, Issue 7, 2000, Pages 317-327

  Archelos, Juan J ^a   Hartung, Hans Peter ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

AUTOIMMUNITY; B LYMPHOCYTE; HUMAN; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; AUTOANTIBODIES; B-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; HUMANS; NERVOUS SYSTEM DISEASES;

EID: 0034237249     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(00)01575-7     Document Type: Review

References (99)

1. 1 Dighiero, G. and Rose, N.R. (1999) Critical self-epitopes are key to the understanding of self-tolerance and autoimmunity. Immunol. Today 20, 423-428
2. 2 Dalmau, J. et al. (1999) Paraneoplastic neurologic syndromes: pathogenesis and physiopathology. Brain Pathol. 9, 275-284
3. 3 Drachman, D.B. (1994) Myasthenia gravis. New Engl. J. Med. 330, 1797-1810
4. 4 Toyka, K.V. et al. (1975) Myasthenia gravis: passive transfer from man to mouse. Science 109, 397-399
5. 2+-flux in a human small cell carcinoma line. Nature 317, 73-75
6. 6 Hartung, H.P. et al. (1995) Immunopathogenesis and treatment of the Guillain-Barré syndrome. Muscle Nerve 18, 137-164
7. 7 Hughes, R.A.C. et al. (1999) Pathogenesis of Guillain-Barré syndrome. J. Neuroimmunol. 100, 74-97
8. 8 Biessels, G.J. et al. (1997) Multifocal motor neuropathy. J. Neurol. 244, 143-152
9. 9 Newsom-Davis, J. and Mills, K.R. (1993) Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Report of five cases and literature review. Brain 116, 453-469
10. + channels of peripheral nerves. Ann. Neurol. 38, 714-722
11. 11 Ropper, A.H. and Gorson, K.C. (1998) Neuropathies associated with paraproteinaemia. New Engl. J. Med. 338, 1601-1607
12. 12 Noseworthy, J.H. (1999) Progress in determining the causes and treatment of multiple sclerosis. Nature 399 (Suppl.), A40-A47
13. 13 Steinman, L. (1999) Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron 24, 511-514
14. 14 Brown, P. and Marsden, C.D. (1999) The stiff man and stiff man plus syndromes. J. Neurol. 246, 648-652
15. 15 Levy, L.M. et al. (1999) The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of the γ-aminobutyric acid. Ann. Intern. Med. 131, 522-530
16. 16 Rogers, S.W. et al. (1994) Autoantibodies to glutamate receptor GluR3 in Rasmussens's encephalitis. Science 265, 648-651
17. 17 Whitney, K.D. and McNamara, J.O. (1999) Autoimmunity and neurological disease: antibody modulation of synaptic transmission. Annu. Rev. Neurosci. 22, 175-195
18. 18 Antel, J. et al. (1998) Clinical Neuroimmunology, Blackwell
19. 19 Genain, C.P. et al. (1999) Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5, 170-175
20. 20 Raine, C.S. et al. (1999) Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann. Neurol. 46, 144-160
21. 21 Pulendran, B. et al. (1997) Immunological tolerance in germinal centres. Immunol. Today 18, 27-32
22. 22 Goodnow, C.C. (1992) Transgenic mice and analysis of B-cell tolerance. Rev. Immunol. 10, 489-518
23. 23 Fulcher, D.A. and Basten, A. (1997) B-cell activation versus tolerance - the central role of immunoglobulin receptor engagement and T-cell help. Int. Rev. Immunol. 15, 33-52
24. 24 Benschop, R.J. and Cambier, J.C. (1999) B cell development: signal transduction by antigen receptors and their surrogates. Curr. Opin. Immunol. 11, 143-151
25. 25 Inaoki, M. et al. (1997) CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J. Exp. Med. 186, 1923-1931
26. 26 O'Keefe, T.L. et al. (1999) Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J. Exp. Med. 189, 1307-1313
27. 27 Henderson, A. and Calame, K. (1998) Transcriptional regulation during B cell development. Annu. Rev. Immunol. 16, 163-200
28. 28 Elkon, K.B. and Marshak-Rothstein, A. (1996) B cells in systemic autoimmune disease: recent insides from Fas-deficient mice and men. Curr. Opin. Immunol. 8, 852-859
29. 29 Anderson, D.E. et al. (1999) The B7-CD28/CTLA-4 costimulatory pathways in autoimmune disease of the central nervous system. Curr. Opin. Immunol. 11, 677-683
30. 30 Silverman, G.J. (1997) B-cell superantigens. Immunol. Today 18, 379-386
31. 31 Vanderlugt, C.T. and Miller, S.D. (1996) Epitope spreading. Curr. Opin. Immunol. 8, 831-836
32. 32 Wang, Z.Y. et al. (1998) T-cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis. Neurology 50, 1045-1054
33. 33 Tuohy, V.K. et al. (1997) Diversity and plasticity of self recognition during the development of multiple sclerosis. J. Clin. Invest. 99, 1682-1690
34. 34 Miller, S.D. et al. (1997) Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3, 1133-1136
35. 35 Gran, B. et al. (1999) Molecular mimicry and multiple sclerosis: degenerate T cell recognition and the induction of autoimmunity. Ann. Neurol 45, 559-567
36. 36 Swedo, S.E. et al. (1998) Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am. J. Psychiatry 155, 264-271
37. 37 Albert, L.J. and Inman, R.D. (1999) Molecular mimicry and autoimmunity. New Engl. J. Med. 341, 2068-2074
38. 38 Gold, R. et al. (1999) Mechanisms of immune regulation in the peripheral nervous system. Brain Pathol. 9, 343-360
39. 39 Pistoia, V. (1997) Production of cytokines by human B cells in health and disease. Immunol. Today 18, 343-350
40. 40 Klinman, D. and Steinberg, A.D. (1987) Systemic autoimmune disease arises from polyclonal B cell activation. J. Exp. Med. 165, 1755-1760
41. 41 Buchwald, B. et al (1998) Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study. Ann. Neurol 44, 913-922
42. 42 Piddlesden, S.J. et al. (1993) The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am. J. Pathol. 143, 555-564
43. 43 Carroll, M.C. (1998) The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol. 16, 545-568
44. 44 Storch, M.K. et al. (1998) Multiple sclerosis: in situ evidence for antibody and complement mediated demyelination. Ann. Neurol. 43, 465-471
45. 45 Hickey, W.F. (1999) Leukocyte traffic in the central nervous system: the participants and their roles. Semin. Immunol. 11, 125-137
46. 46 Lyons, J.A. et al. (1999) B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encepalitogenic peptide. Eur. J. Immunol. 29, 3432-3439
47. 47 Griffiths, M.M. et al. (1999) Mapping autoimmunity genes. Curr. Opin. Immunol. 11, 689-700
48. 48 Brekke, O.H. et al. (1995) The structural requirements for complement activation by IgG: does it hinge on the hinge? Immunol. Today 16, 85-90
49. 49 Stefferl, A. et al. (1999) Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the 'resistant' Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B-cell response. J. Immunol. 163, 40-49
50. 50 Kohler, H. and Paul, S. (1998) Superantibody activities: new players in innate and adaptive immune responses. Immunol. Today 19, 221-227
51. 51 Furneaux, H.F. et al. (1990) Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurology 40, 1085-1091
52. 52 Weinshenker, B.G. et al. (1999) A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann. Neurol. 46, 878-886
53. 53 Rubin, L.L. and Staddon, J.M. (1999) The cell biology of the blood-brain barrier. Annu. Rev. Neurosci. 22, 11-28
54. 54 Buchwald, B. et al. (1999) Neonatal Guillain-Barré syndrome. Blocking antibodies transmitted from mother to child. Neurology 53, 1246-1253
55. 55 Illa, I. et al. (1995) Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides. Ann. Neurol 38, 218-224
56. 56 Archelos J.J. et al. (1998) Isolation and characterization of an oligodendrocyte-precursor-derived B cell epitope in multiple sclerosis. Ann. Neurol. 43, 15-24
57. 57 Reichlin, M. (1995) Cell injury by autoantibodies to intracellular antigens. Clin. Immunol. Immunopathol. 76, 215-219
58. 58 Greenlee, J.E. et al. (1995) Uptake of systemically administered human anticerebellar antibody by rat Purkinje cells following blood-brain barrier disruption. Acta Neuropathol. 89, 341-345
59. 59 Benyahia, B. et al. (1999) Cell-mediated autoimmunity inparaneoplastic neurological syndromes with anti-Hu antibodies. Ann. Neurol. 45, 162-167
60. 60 Albert, L.M. et al. (2000) Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann. Neurol. 47, 9-17
61. 61 Moalem, G. et al. (1999) Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5, 49-55
62. 62 Asakura, K. et al. (1998) Targeting of IgMkappa antibodies to oligodendrocytes promotes CNS remyelination. J. Neurosci. 18, 7700-7708
63. 63 Casali, P. and Notkins, A.L. (1989) Probing the human B-cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes. Ann. Rev. Immunol. 7, 513-535
64. 64 Mix, E. et al. (1990) B cells expressing CD5 are increased in cerebrospinal fluid of patients with multiples sclerosis. Clin. Exp. Immunol. 79, 21-27
65. 65 Hurez, V. et al. (1997) Pooled normal human polyspecific IgG contains neutralizing anti-idiotypes to IgG autoantibodies of autoimmune patients and protects from experimental autoimmune disease. Blood 90, 4004-4013
66. 66 Kerschensteiner, M. et al. (1999) Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J. Exp. Med. 189, 865-870
67. 67 Ebadi, M. et al. (1997) Neurotrophins and their receptors in nerve injury and repair. Neurochem. Int. 30, 347-374
68. 68 Mufson, E.J. et al. (1999) Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases. Prog. Neurobiol. 57, 451-484
69. 69 Giehl, K.M. and Tetzlaff, W. (1996) BDNF and NT-3, but not NGF, prevent axotomy-induced death of rat corticospinal neurons in vivo. Eur. J. Neurosci. 8, 1167-1175
70. 70 Ferguson, B. et al. (1997) Axonal damage in acute multiple sclerosis lesions. Brain 120, 393-399
71. 71 Trapp, B.D. et al. (1998) Axonal transection in the lesions of multiple sclerosis. New Engl. J. Med. 338, 278-285
72. 72 Perry, V.H. (1998) A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation. J. Neuroimmunol. 90, 113-121
73. 73 Esiri, M.M. and Gay D. (1990) Immunological and neuropathological significance of the Virchow-Robin space. J. Neurol. Sci. 100, 3-8
74. 74 Weller, R.O. (1998) Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease, prion disorders and multiple sclerosis. J. Neuropathol. Exp. Neurol. 57, 885-894
75. 75 Harling-Berg, C.J. et al. (1999) Role of the cervical lymphatics in the Th2-type hierarchy of CNS immune regulation. J. Neuroimmunol. 101, 111-127
76. 76 Prineas, J.W. (1979) Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord. Science 203, 1123-1125
77. 77 Katz, D. et al. (1993) Correlation between magnetic resonance imaging and lesion development in chronic active multiple sclerosis. Ann. Neurol. 34, 661-669
78. 78 Litzenburger, T. et al. (1998) B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J. Exp. Med. 188, 169-180
79. 79 Sørensen, T.L. et al. (1999) Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 103, 807-815
80. 80 Baggiolini, M. (1998) Chemokines and leukocyte traffic. Nature 392, 565-568
81. 81 Griffin, D.E. et al. (1992) The immune response in viral encephalitis. Semin. Immunol. 4, 111-119
82. 82 Borrow, P. et al. (1995) Immunization-induced inflammatory infiltration of the central nervous system in transgenic mice expressing a microbial antigen in astrocytes. J. Neuroimmunol. 61, 133-149
83. 83 von Herrath, M.G. et al. (1996) Using transgenic mouse models to dissect the pathogenesis of virus-induced autoimmune disorders of the islets of Langerhans and the central nervous system. Immunol. Rev. 152, 111-143
84. 84 Knopf, P.M. et al. (1998) Antigen-dependent intrathecal antibody synthesis in the normal rat brain: tissue entry and local retention of antigen-specific B cells. J. Immunol. 161, 692-701
85. 85 Wucherpfennig, K. and Strominger, J.L. (1995) Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80, 695-705
86. 86 Panitch, H.S. (1994) Influence of infection on exacerbations of multiple sclerosis. Ann. Neurol. 36, S25-S28
87. 87 Bashir, R. et al. (1991) SCID/human mouse model of central nervous system lymphoproliferative disease. Lab. Invest. 65, 702-709
88. H4 germline segments in an acute multiple sclerosis brain. Ann. Neurol. 43, 236-243
89. 89 Baranzini, S.E. et al. (1999) B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J. Immunol. 163, 5133-5144
90. 90 Guseo, A. and Jellinger, K. (1975) The significance of perivascular infiltrations in multiple sclerosis. J. Neurol. 211, 51-60
91. 91 Esiri, M.M. (1977) Immunoglobulin-containing cells in multiple sclerosis plaques. Lancet 2, 478-480
92. 92 Prineas, J.W. and Wright, R.G. (1978) Macrophages, lymphocytes and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab. Invest. 38, 409-421
93. 93 Cannella, B. and Raine, C.S. (1995) The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37, 424-435
94. 94 Massaro, A.R. and Tonali, P. (1998) Cerebrospinal fluid markers in multiple sclerosis: an overview. Mult. Scler. 4, 1-4
95. 95 Gerritse, K. et al. (1996) CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 93, 2409-2504
96. 96 Ulvestad, E. et al. (1994) Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG. J. Neurol Sci. 121, 125-131
97. 97 Raine, C.S. et al. (1984) Adoptively transferred chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Neuropathologic analysis. Lab. Invest. 51, 534-546
98. 98 Stott, D.I. et al. (1998) Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. J. Clin. Invest. 102, 938-946
99. 99 Sacca, R. et al. (1997) Mediators of inflammation. Curr. Opin. Immunol. 9, 851-857